Biohaven Ltd., a biopharmaceutical company, focuses on the discovery, development, and commercialization of treatments for immunology, neuroscience, and oncology therapeutic areas worldwide. It develops BHV-1300, which is in Phase 2 clinica...
Leadership
Vladimir Coric M.D.
Chairman & CEO
Matthew Buten
Chief Financial Officer
Bruce D. Car DACVP, Ph.D.
Chief Scientific Officer
Kimberly Gentile
Senior Vice President of Clinical Operations
Deb Young
Senior Director of Regulatory Affairs & Operations
George C. Clark CPA
VP & Chief Accounting Officer
John McGill
Chief Technology Officer
Jennifer Porcelli
Vice President of Investor Relations
Warren Volles J.D.
General Counsel & Chief Legal Officer
Clifford Bechtold M.S.
President & GM of Biohaven Ireland Chief Compliance Officer
